Overexpression of MMP-13 gene in colorectal cancer with liver metastasis

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2693-2699

  Yamada, Takanobu ^a   Oshima, Takashi ^b   Yoshihara, Kazue ^b   Tamura, Shuzo ^a   Kanazawa, Amane ^a   Inagaki, Daisuke ^a   Yamamoto, Naoto ^a   Sato, Tsutomu ^b   Fujii, Shoichi ^b   Numata, Kazushi ^b   Kunisaki, Chikara ^b   Shiozawa, Manabu ^a   Morinaga, Soichiro ^a   Akaike, Makoto ^a   Rino, Yasushi ^c   Tanaka, Katsuaki ^b   Masuda, Munetaka ^c   Imada, Toshio ^c  

^a KANAGAWA CANCER CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Liver metastasis; MMP 13

Indexed keywords

BETA ACTIN; COLLAGENASE 3; GELATINASE B; MATRILYSIN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CANCER TISSUE; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; INTESTINAL MUCOSA; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM METASTASIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 77955779515     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ: Cancer statistics. CA Cancer J Clin 55: 10-30, 2005.
2. Greenwold P: Colon cancer overview. Cancer 70: 1206-1215, 1992.
3. Liotta LA and Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054-5059, 1991.
4. Wagenaar-Miller RA, Gorden L and Mtrisian LM: Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev 23: 119-135, 2004.
5. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM and Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68, 1980. (Pubitemid 10098769)
6. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991
7. Vihinen P and Kähäri V-M: Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99: 157-166, 2002.
8. Kerkelä E and Saarialho-Kere U: Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol 12: 109-125, 2003. (Pubitemid 36934696)
9. Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y, Nakai N and Okada Y: Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J Biol Chem 270: 6691-6697, 1995.
10. Remy L, Trespeuch C, Bachy S, Scoazec JY and Rousselle P: Matrilysin 1 influences colon carcinoma cell migration by cleavage of the laminin-5 b3 chain. Cancer Res 66: 11228-11237, 2006.
11. Impola U, Jeskanen L, Ravanti L, Syrjänen S, Baldursson B, Kähäri VM and Saarialho-Kere U: Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds. Br J Dermatol 152: 720-726, 2005.
12. Mook ORF, Frederiks WM and Van Noorden CJF: The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705: 69-89, 2004. (Pubitemid 39592897)
13. Freije JM, Díez-Itza I, Balbín M, Sánchez LM, Blasco R, Tolivia J and López-Otín C: Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269: 16766-16773, 1994.
14. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF and Hambor JE: Cloning, expression and type 11 collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97: 761-768, 1996.
15. Leeman MF, McKay JA and Murray GI: Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer J Clin Pathol 55: 758-762, 2002.
16. Etoh T, Inoue H, Yoshikawa Y, Barnard GF, Kitano S and Mori M: Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness. Gut 47: 50-56, 2000.
17. Heppner KJ, Matrisian LM, Jensen RA and Rodgers WH: Expression of most matrix metalloproteinase family members in breast cancer represents a tumour-induced host response. Am J Pathol 149: 273-282, 1996.
18. Boström PJ, Ravanti L, Reunanen N, Aaltonen V, Söderström KO, Kähäri VM and Laato M: Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. Int J Cancer 88: 417-423, 2000.
19. Cazorla M, Hernández L, Nadal A, Balbín M, López JM, Vizoso F, Fernández PL, Iwata K, Cardesa A, López-Otín C, Campo E: Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol 186: 144-150, 1998.
20. Johansson N, Vaalamo M, Grénman S, Hietanen S, Klemi P, Saarialho-Kere U and Kähäri VM: Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol 154: 469-480, 1999.
21. Johansson N, Airola K, Grénman R, Kariniemi AL, Saarialho-Kere U and Kähäri VM: Expression of collagenase-3 (matrix metalloproteinase 13) in squamous cell carcinomas of the head and neck. Am J Pathol 151: 499-508, 1997.
22. Luukkaa M, Vihinen P, Kronqvist P, Vahlberg T, Pyrhonen S, Kahari VM and Grenman R: Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer. Head Neck 28: 225-234, 2006. (Pubitemid 43269889)
23. Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R and Murray GI: Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res 10: 8229-8234, 2004.
24. Zhang B, Cao X, Liu Y, Cao W, Zhang F, Zhang S, Li H, Ning L, Fu L, Niu Y, Niu R, Sun B and Hao X: Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer. BMC Cancer 8: 83, 2008.
25. Bartsch JE, Staren ED and Appert HE: Matrix metalloproteinase expression in breast cancer. J Surg Res 110: 383-392, 2003. (Pubitemid 36683036)
26. Corte MD, Gonzalez LO, Corte MG, Quintela I, Pidal I, Bongera M and Vizoso F: Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma. Int J Biol Markers 20: 242-248, 2005.
27. Dunne AA, Sesterhenn A, Gerisch A, Teymoortash A, Kuropkat C and Werner JA: Expression of MMP-2, -9 and -13 in cell lines and fresh biopsies of squamous cell carcinomas of the upper aerodigestive tract. Anticancer Res 23: 2233-2239, 2003.
28. Bostrom PJ, Ravanti L, Reunanen N, Aaltonen V, Soderstrom KO, Kahari VM and Laato M: Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. Int J Cancer 88: 417-423, 2000.
29. Knäuper V, López-Otin C, Smith B, Knight G and Murphy G: Biochemical characterization of human collagenase-3. J Biol Chem 271: 1544-1550, 1996.
30. Knäuper V, Will H, López-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM and Murphy G: Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 271: 17124-17131, 1996.
31. Knäuper V, Smith B, López-Otin C, Murphy G: Activation of progelatinase b (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem 248: 369-373, 1997. (Pubitemid 27387479)
32. Cowell S, Knäuper V, Stewart ML, D'Ortho MP, Stanton H, Hembry RM, López-Otín C, Reynolds JJ and Murphy G: Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase a, gelatinase b and collagenase 3. Biochem J 331: 453-458, 1998.
33. Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, Benyon C and Iredale JP: Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem 277: 11069-11076, 2002. (Pubitemid 34952866)
34. Boudreau N, Sympson CJ, Werb Z and Bissell MJ: Suppression of ICE and apoptosis in mammary epithelial cells by extracellular-matrix. Science 267: 891-893, 1995.
35. Alexander CM, Howard EW, Bissell MJ and Werb Z: Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J Cell Biol 135: 1669-1677, 1996. (Pubitemid 127558407)
36. Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A and Stetler-Stevenson M: In vitro suppression of programmed cell death of B-cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 102: 2002-2010, 1998.
37. Hornebeck W, Lambert E, Petitfrere E and Bernard P: Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression. Biochimie 87: 377-383, 2005.
38. Liu SC, Yang SF, Yeh KT, Yeh CM, Chiou HL, Lee CY, Chou MC and Hsieh YS: Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer. Clin Chim Acta 371: 92-96, 2006. (Pubitemid 44162898)
39. Wurtz SO, Schrohl AS, Sorensen NM, Lademann U, Christensen IJ, Mouridsen H and Brunner N: Tissue inhibitor of metalloproteinases-1 in breast cancer. Endocr Relat Cancer 12: 215-27, 2005.
40. Stetler-Stevenson WG: Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 9: 289-303, 1990.
41. Chambers AF and Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270, 1997. (Pubitemid 27371946)
42. Illemann M, Bird N, Majeed A, Sehested M, Laerum OD, Lund LR, Danø K and Nielsen BS: MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol Cancer Res 4: 293-302, 2006.
43. Zeng ZS, Huang Y, Cohen AM and Guillem JG: Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 14: 3133-3140, 1996. (Pubitemid 26408807)
44. Kähäri VM, Johansson N, Grénman R, Airola K and Saarialho-Kere U: Expression of collagenase-3 (MMP-13) by tumor cells in squamous cell carcinomas of the head and neck. Adv Exp Med Biol 451: 63-68, 1998.
45. Zeng ZS, Shu WP, Cohen AM and Guillem JG: Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. Clin Cancer Res 8: 144-148, 2002.
46. Mori M, Barnard GF, Mimori K, Ueo H, Akiyoshi T and Sugimachi K: Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer 75: 1516-1519, 1995.
47. Adachi Y, Yamamoto H, Itoh F, Hinoda Y, Okada Y and Imai K: Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 45: 252-258, 1999.
48. Miyata Y, Iwata T, Ohba K, Kanda S, Nishikido M and Kanetake H: Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis. Clin Cancer Res 12: 6998-7003, 2006. (Pubitemid 44974495)
49. Pesta M, Topolcan O, Holubec L Jr, Rupert K, Cerna M, Holubec LS, Treska V, Finek J and Cerny R: Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples. Anticancer Res 27: 1863-1867, 2007.
50. Kim TD, Song KS, Li G, Choi H, Park HD, Lim K, Hwang BD and Yoon WH: Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. BMC Cancer 6: 211, 2006.
51. Lubbe WJ, Zhou ZY, Fu W, Zuzga D, Schulz S, Fridman R, Muschel RJ, Waldman SA and Pitari GM: Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer. Clin Cancer Res. 12: 1876-1882, 2006.
52. Offenberg H, Brünner N, Mansilla F, Orntoft Torben F and Birkenkamp-Demtroder K: TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles. Mol Oncol 2: 233-240, 2008.
53. Asano T, Tada M, Cheng S, Takemoto N, Kuramae T, Abe M, Takahashi O, Miyamoto M, Hamada J, Moriuchi T and Kondo S: Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma. J Surg Res 146: 32-42, 2008
54. Nosho K, Yamamoto H, Taniguchi H, Adachi Y, Yoshida Y, Arimura Y, Endo T, Hinoda Y and Imai K: Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis. Clin Cancer Res 10: 7950-7957, 2004.
55. Ogata Y, Matono K, Sasatomi T, Ishibashi N, Ohkita A, Mizobe T, Ogo S, Ikeda S, Ozasa H and Shirouzu K: The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer. Cancer Chemother Pharmacol. 57: 577-583, 2006.
56. Ogawa M, Ikeuchi K, Watanabe M, Etoh K, Kobayashi T, Takao Y, Anazawa S and Yamazaki Y: Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach. Hepatogastroenterology. 52: 875-880, 2005.
57. Zeng ZS and Guillem JG: Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancer. Br J Cancer 78: 349-353, 1998.
58. Matsuyama Y, Takao S and Aikou T: Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. J Surg Oncol 80: 105-110, 2002. (Pubitemid 34569178)
59. Kopitz C, Gerg M and Bandapalli OR: Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. Cancer Res. 67: 8615-8623, 2007.